Forge Development Partners is set to purchase Wells Fargo's 409,000-square-foot headquarters at 420 Montgomery Street in San ...

Wells Fargo’s headquarters building could be converted into housing after a possible sale, in what would be a major project for San Francisco’s struggling downtown. The banking giant is in talks to ...

Wells Fargo & Co., an American multinational financial services company, is planning to make its largest investment in tech ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and therefore flagged by the Imperva network. Imperva displays this page for you ...

Fintel reports that on April 11, 2025, Wells Fargo initiated coverage of Sarepta Therapeutics (NasdaqGS:SRPT) with a ...

Sarepta Therapeutics (NASDAQ:SRPT) stock draws an Overweight rating at Wells Fargo, based on commercial prospects for ...

Wells Fargo reported better-than-expected quarterly earnings, though CEO Charlie Scharf said the bank is bracing for a slower ...

(Reuters) - Wells Fargo's profit rose 6% in the first quarter as the bank cut costs and set aside less money to cover ...

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of ...

Wells Fargo bought back 44.5 million of its own shares, worth $3.5 billion, in first quarter. The San Francisco-based lender ...

Wells Fargo initiated coverage of Sarepta (SRPT) with an Overweight rating and $115 price target Despite the recent Gr5 AE case, the firm ...

April 4 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab said on Friday it had temporarily halted three trials testing its gene therapy Elevidys, following the death of a patient last ...